Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither? - Wikidata - wikimedia - TriplyDB

Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?

Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?

http://www.wikidata.org/entity/Q51815043

about

Biomarkers for hepatocellular carcinoma Biomarkers: evaluation of screening for and early diagnosis of hepatocellular carcinoma in Japan and china Adult mouse model of early hepatocellular carcinoma promoted by alcoholic liver disease Diagnosis of hepatocellular carcinoma.The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis.Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence.Proteomic expression signature distinguishes cancerous and nonmalignant tissues in hepatocellular carcinoma.Eurycomanone induce apoptosis in HepG2 cells via up-regulation of p53 Tumor-associated autoantibodies are useful biomarkers in immunodiagnosis of α-fetoprotein-negative hepatocellular carcinoma Is inconsistency of alpha-fetoprotein level a good prognosticator for hepatocellular carcinoma recurrence?Association of serum microRNA expression in hepatocellular carcinomas treated with transarterial chemoembolization and patient survival.Measurement of glycosylated alpha-fetoprotein improves diagnostic power over the native form in hepatocellular carcinoma Potential therapeutic role of Tridham in human hepatocellular carcinoma cell line through induction of p53 independent apoptosis High Expression of FLOT1 Is Associated with Progression and Poor Prognosis in Hepatocellular Carcinoma Presentation and outcomes of hepatocellular carcinoma patients at a western centre.Identification of HBV-MLL4 Integration and Its Molecular Basis in Chinese Hepatocellular Carcinoma.The promise of metabolic phenotyping in gastroenterology and hepatology.Autoantibodies against tumor-associated antigens for detection of hepatocellular carcinoma Expression of cancer stem cell biomarkers as a tool for a correct therapeutic approach to hepatocellular carcinoma.Utility of serum des-gamma-carboxyprothrombin in the diagnosis of hepatocellular carcinoma among Nigerians, a case-control study Trial watch: Naked and vectored DNA-based anticancer vaccines An Analysis of Immunoreactive Signatures in Early Stage Hepatocellular Carcinoma.Analysis of DNA methylation in plasma for monitoring hepatocarcinogenesis Serum LncRNAs Profiles Serve as Novel Potential Biomarkers for the Diagnosis of HBV-Positive Hepatocellular Carcinoma.Glypican-3 expression and its relationship with recurrence of HCC after liver transplantation.Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.Value of quantitative and qualitative analyses of circulating cell-free DNA as diagnostic tools for hepatocellular carcinoma: a meta-analysis.Circulating tumor cells measurements in hepatocellular carcinoma.Alpha-Fetoprotein Detection of Hepatocellular Carcinoma Leads to a Standardized Analysis of Dynamic AFP to Improve Screening Based Detection.Extrahepatic recurrence of hepatocellular carcinoma after curative hepatic resection.Persistent increase in alpha-fetoprotein level in a patient without underlying liver disease who underwent curative resection of hepatocellular carcinoma. A case report and review of the literature Osteopontin and latent-TGF β binding-protein 2 as potential diagnostic markers for HBV-related hepatocellular carcinoma.Up-regulation of AKAP13 and MAGT1 on cytoplasmic membrane in progressive hepatocellular carcinoma: a novel target for prognosis.The Microbiome and Cancer: Is the 'Oncobiome' Mirage Real?Targeted deep sequencing of plasma circulating cell-free DNA reveals Vimentin and Fibulin 1 as potential epigenetic biomarkers for hepatocellular carcinoma.Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation.Diffuse infiltrative hepatocellular carcinoma: assessment of presentation, treatment, and outcomes Effects of loco regional treatments before living donor liver transplantation on overall survival and recurrence-free survival in South Korean patients with hepatocellular carcinoma.Surveillance of cirrhosis for hepatocellular carcinoma: a cost-utility analysis Phenotype and function of CXCR5+CD45RA-CD4+ T cells were altered in HBV-related hepatocellular carcinoma and elevated serum CXCL13 predicted better prognosis.

P2860

Q21285158-F283B96F-ED69-4B8F-9BB7-59D8575E7AED Q27003291-166CDD36-CC22-4FAC-84E6-D9DB5A472269 Q28834514-2AC56F84-0CE2-4213-8B06-CC7712E970AC Q30490554-0C4CFBE3-1E69-4658-A7D3-61430A66DB92 Q33272872-43DE8DAF-2E85-42CA-8781-C50457030EBA Q33302500-EA22E8EF-24C7-40E4-A5F3-FA5AB2207944 Q33401908-5B1C2C19-EFCB-4F9D-9C09-C98C6C3461CC Q33464737-2FC213A6-9AF6-47C8-ADB4-E737AAD6FFA8 Q33719973-3808CA56-08C0-4D6F-B2A7-BB03F2B01A70 Q33935625-32D721D5-010C-45E6-9DF9-06CA5BE030CE Q34282931-FF77C35A-36B4-45DF-8923-849355D4C35F Q34332296-5C4FA35C-E1FA-4E23-B2BD-A289E19D90EC Q34464794-2FA65E11-37BA-465B-8B4E-DD478E52DBC8 Q34804240-97001E2E-E3FF-4D21-8870-D195F045DAE9 Q35535968-E21995EF-B010-4D91-AFA0-2952770BBCDD Q35611332-7F4DE564-1D5F-4C35-86CD-E9565C8CAE47 Q35701279-89DB5BB2-1038-4112-B14C-E72ECADE49D1 Q35715964-002C9B9A-B799-4320-B7DD-E3FDBAFBCF44 Q35745018-6C8BAE3C-01F2-4996-8DB0-5CAF506B977B Q35764990-81754683-769A-4DBD-9C4F-9E36598E2976 Q35798986-3E4AF500-E8A7-4347-85DF-A1E997C368C0 Q35800748-56BC0205-8948-4DD7-B300-1197FC3FB857 Q35804238-BCA5E74E-E6E4-4654-9B14-8A6A6F43B9F0 Q35870607-880F3B82-FA93-421E-A8C2-5D5CD1930737 Q35963772-7069CE5F-E365-4034-BC69-2AA15CEAE26C Q35987232-9D2FE2C4-F79D-4E88-9496-82943EF6A7D6 Q36009225-759983D2-F066-476C-A59E-8387BE2A4CEF Q36011412-B128ACE9-A79B-468F-80AD-010DFE9001C2 Q36053838-15619CFA-EC78-4A39-8DEC-1FF5967D303A Q36072833-C7B55CE8-74A3-46FB-A8EA-9F9110E34371 Q36125548-C1763B94-03D2-4509-B4AF-0D0D90F4CA21 Q36198665-C1AA6E5C-C8F3-41D2-A365-6F996CC10B26 Q36262183-6C8A0B4A-2F76-4E97-AB5F-D7859922296F Q36272668-097898AA-9E5E-43C4-926C-01AD04EB7D4A Q36319775-82732D1C-4442-49CE-ACA4-92092D4E6662 Q36497062-706B1DC9-5311-42EB-AE17-537AEC3A2688 Q36512761-ABFAC8EE-A3F6-4C7F-A114-1CF805145B48 Q36570317-D4121F8E-543F-43F4-BD96-5E93C9422FE0 Q36608549-2140E6F0-4B2B-4109-A637-A5A58E938E31 Q36688945-834199DE-2BA6-4027-B6B8-AFD0DC1FDFDB

P2860

Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?

http://www.wikidata.org/entity/Q51815043

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Diagnostic and prognostic role ...... ar carcinoma: both or neither?

@en

Diagnostic and prognostic role ...... ar carcinoma: both or neither?

@nl

type

label

Diagnostic and prognostic role ...... ar carcinoma: both or neither?

@en

Diagnostic and prognostic role ...... ar carcinoma: both or neither?

@nl

prefLabel

Diagnostic and prognostic role ...... ar carcinoma: both or neither?

@en

Diagnostic and prognostic role ...... ar carcinoma: both or neither?

@nl

P1433

Q51815043-04005538-84D4-4D5B-8030-24A870422E82

P1476

Q51815043-FB06DF85-7EF8-44A0-AF77-59CB41C02FC7

P2093

Q51815043-178178D5-A4F9-4F52-ACF0-B5D50F336F4F

Q51815043-504F9547-7BA0-4DB5-95E3-DD7A5834C422

Q51815043-58FD7AE9-4A53-4A61-889F-667110964406

Q51815043-5B24D38A-B8D9-4B94-9B81-8BDDA46F55D1

Q51815043-6B0B5747-E0B9-439A-966F-8A2B2838166D

Q51815043-7EA08EA2-F9B3-4AB9-A919-120A3E2F0D40

Q51815043-8AAA73EE-32E2-4462-B47C-E29A2C424AB0

Q51815043-9F74699A-9529-47E5-B29A-A97BEE69CFDA

Q51815043-C6065056-A132-4A2D-B153-3CD2AAD8EDA7

Q51815043-CEC77FD0-6933-49E2-9DF0-CBC9A00903AD

P2860

Q51815043-023588AA-A027-430D-8C77-FDE4EE954FFE

Q51815043-03268AAA-83A3-47D3-B994-F1462F313D4E

Q51815043-0BA84F93-F57E-4C28-8983-30E3C7F451FE

Q51815043-1A64AF71-4AEB-4B79-8E1E-9B04DB0A97DA

Q51815043-1B7A6A10-29C2-4445-AB4B-27A1184420DE

Q51815043-1C0D7728-216B-4CDF-9187-80479D27721D

Q51815043-2D85703E-564A-4280-B2B5-45C4543B7F21

Q51815043-307E3461-C5AF-4EE0-BBEB-D023537A8EDE

Q51815043-3BC91108-6F24-440C-918F-C7AAB3E9BD5A

Q51815043-61F22199-AE43-4A7F-842B-1A0D52E659C5

P304

Q51815043-563A5132-B4E6-4B92-8A4F-EBC88B6150E0

P31

Q51815043-85448337-60D5-4E43-AA1B-05EA564020C6

P356

Q51815043-D411D8F9-5725-48E9-90CE-1C7BFAD4B615

P407

Q51815043-D03B35DE-286C-4068-9D85-DE0A7B8BD92D

P433

Q51815043-69C3887B-3507-4BFA-A3C4-F3E661677273

P478

Q51815043-61F0CF79-3CFC-45BF-97A2-148E241006AD

P50

Q51815043-54414C80-73A9-4DC9-8A2B-FB945D938E24

P577

Q51815043-34A453C5-EE55-4A89-9B1C-5882D9428323

P698

Q51815043-D1492F97-70D5-4298-A0F9-C555C9111219

P921

Q51815043-62c2876e-9bc9-4fb9-8fa1-17be62f05c84

P356

J.1572-0241.2006.00443.X

P1433

The American Journal of Gastroenterology

P1476

Diagnostic and prognostic role ...... ar carcinoma: both or neither?

@en

P2093

Anna Baldan

http://www.w3.org/2001/XMLSchema#string

Dario Marino

http://www.w3.org/2001/XMLSchema#string

Fabio Farinati

http://www.w3.org/2001/XMLSchema#string

Franco Borzio

http://www.w3.org/2001/XMLSchema#string

Franco Trevisani

http://www.w3.org/2001/XMLSchema#string

Gianludovico Rapaccini

http://www.w3.org/2001/XMLSchema#string

Luisa Benvegnù

http://www.w3.org/2001/XMLSchema#string

Marco Zoli

http://www.w3.org/2001/XMLSchema#string

Maria Anna Di Nolfo

http://www.w3.org/2001/XMLSchema#string

Maria Cantarini

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

The promoting molecular mechanism of alpha-fetoprotein on the growth of human hepatoma Bel7402 cell line.

Screening for cancer in viral hepatitis.

Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis.

Clinical characteristics and prognosis of hepatocellular carcinoma: analysis based on serum alpha-fetoprotein levels.

Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status.

Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature.

Issues in screening and surveillance for hepatocellular carcinoma.

Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma.

Use of tamoxifen in advanced-stage hepatocellular carcinoma. A systematic review.

P304

524-532

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1572-0241.2006.00443.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

Carmela Cursaro

P577

2006-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16542289

http://www.w3.org/2001/XMLSchema#string

P921